Cuba studied 11,092 samples for COVID-19, resulting in 75 positive ones. The country accumulates 1,146,603 samples carried out and 8,531 positive (0.74%).

The Pedro Kourí Institute of Tropical Medicine (IPK), in Havana, will host this Thursday the main event for the Latin American Medicine Day, which is celebrated every December 3, in remembrance of the birth of Carlos J. Finlay, eminent Cuban scientist and physician.

Lisdanay Escalona Sosa takes part in her free time, and without receiving any compensation, to prevent the Human Immunodeficiency Virus in conversations with students from junior high and high school.

The Cuban health ministry reported today 97 new positive cases of SARS-CoV-2, coronavirus that causes COVID-19, for a total of 8,381 in the country.

Cuba´s international medical brigade Henry Reeve was nominated today for the 2021 Nobel Peace Prize by an accredited Thai academic.

Cuba´s National Public Health System closes the year with a decrease in the cases diagnosed with the Human Immunodeficiency Virus (HIV), as well as the mortality associated with this epidemic, which reflects a control over the transmission of HIV /AIDS.

The Cuban health ministry reported today 51 new positive cases of SARS-CoV-2, coronavirus that causes COVID-19, for a total of 8,284 in the country.

The proposal of the Henry Reeve contingent of Cuban international doctors to the Nobel Peace Prize counts with the support of the Association of Nicaraguan Doctors Graduated from the Latin American School of Medicine (ELAM), in Cuba.

Cuba studied 10, 921 samples for COVID-19, resulting in 35 positive ones. The country accumulates 1,083,028 samples carried out and 8,110 positive (0.75%).
At the close of November 26, there are 3,613 patients in hospital for clinical epidemiological surveillance, 872 suspects, 2,291 in surveillance and 450 confirmed.

The United Nations Educational, Scientific and Cultural Organization (UNESCO) awarded the Carlos J. Finlay Prize, sponsored by Cuba, to Professor Kenya Honda, of the Department of Microbiology and Immunology of Keio University's School of Medicine (Tokyo).

The Regulatory Authority of Drugs, Equipment and Medical Devices of the Republic of Cuba (CECMED by its Spanish acronym) approved today the beginning of clinical trials of COVID-19 vaccine candidates Mambisa and Abdala.

Cuba studied 10,596 samples for COVID-19, resulting 49 positive ones. The country accumulates 1, 72,107 samples made and 8, 75 positive (0.75%).
At the close of November 25, 3,627 patients remain in hospital for clinical epidemiological surveillance, 799 suspected, 2,385 under surveillance and 443 confirmed.

To continue fulfilling the collaboration agreements between Cuba and Venezuela, 197 new Cuban doctors arrived in Caracas and joined to provide services, along with the 1,300 who work there, mainly in the fight against the COVID-19 pandemic.

In Cuba, more than 93% of the patients who have been infected with COVID-19 have recovered, a figure above the world average, which barely exceeds 69%; this reality shows how much has been done in the country in more than eight months of hard battle to save lives.